Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19

NCT04252274 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

30

Enrollment

OTHER_GOV

Sponsor class

Conditions

Pneumonia, Pneumocystis
Coronavirus

Interventions

DRUG: Darunavir and Cobicistat

Sponsor

Shanghai Public Health Clinical Center